BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 18158195)

  • 1. Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: association with connective tissue disorder severity.
    Gold DG; Miller RC; Pinn ME; Osborn TG; Petersen IA; Brown PD
    Radiother Oncol; 2008 Apr; 87(1):127-31. PubMed ID: 18158195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic Experience.
    Pinn ME; Gold DG; Petersen IA; Osborn TG; Brown PD; Miller RC
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):498-506. PubMed ID: 18164848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus.
    Khorshid O; Hosing C; Bibawi S; Ueno N; Reveille J; Mayes MD; Champlin RE
    J Rheumatol; 2004 Dec; 31(12):2513-6. PubMed ID: 15570660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired ichthyosis associated with an overlap syndrome of systemic sclerosis and systemic lupus erythematosus.
    Lee HW; Ahn SJ; Choi JC; Chang SE; Choi JH; Moon KC; Koh JK
    J Dermatol; 2006 Jan; 33(1):52-4. PubMed ID: 16469086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of survival among patients with connective tissue disease and cardiomyopathy (systemic sclerosis, systemic lupus erythematosus, and undifferentiated disease).
    Leyngold I; Baughman K; Kasper E; Ardehali H
    Am J Cardiol; 2007 Aug; 100(3):513-7. PubMed ID: 17659938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy for malignancy in patients with scleroderma: The Mayo Clinic experience.
    Gold DG; Miller RC; Petersen IA; Osborn TG
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):559-67. PubMed ID: 17236971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue disease.
    Christopher-Stine L; Wigley F
    J Rheumatol; 2003 Dec; 30(12):2725-7. PubMed ID: 14719225
    [No Abstract]   [Full Text] [Related]  

  • 8. [M scleroderma (with systemic progressive sclerosis) associated with clinical and biological signs of dermatomyositis and lupus erythematosus].
    Grupper C; Durepaire RM; Eisenmann D; Briche R
    Bull Soc Fr Dermatol Syphiligr; 1972; 79(3):219-20. PubMed ID: 4642837
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxicity of radiotherapy in patients with collagen vascular disease.
    Lin A; Abu-Isa E; Griffith KA; Ben-Josef E
    Cancer; 2008 Aug; 113(3):648-53. PubMed ID: 18506734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus and breast cancer.
    Kontos M; Fentiman IS
    Breast J; 2008; 14(1):81-6. PubMed ID: 18186868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ichthyotic-appearing skin changes associated with childhood morphea, systemic sclerosis, and systemic lupus erythematosus/scleroderma overlap.
    Williams CM; Storm CA; Burns C; Rigby W; Dinulos JG
    Pediatr Dermatol; 2010; 27(2):170-3. PubMed ID: 20537069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SLE, progressive systemic sclerosis, polymyositis, MCTD and the vascular lesions].
    Hashimoto H; Hirose S
    Nihon Rinsho; 1985 Oct; 43(10):2070-6. PubMed ID: 3912534
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pulmonary vascular disease with pulmonary hypertension in collagen disease].
    Sawai T; Kyogoku M
    Kokyu To Junkan; 1986 Jan; 34(1):59-67. PubMed ID: 3961292
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in otorhinolaryngological organs in systemic lupus erythematosus and systemic scleroderma].
    Minchin RA; Nasonova VA
    Klin Med (Mosk); 1970 Jun; 48(6):129-34. PubMed ID: 5523975
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical features of lung cancer in patients with connective tissue diseases: a 10-year hospital based study.
    Adzić TN; Pesut DP; Nagorni-Obradović LM; Stojsić JM; Vasiljević MD; Bouros D
    Respir Med; 2008 Apr; 102(4):620-4. PubMed ID: 18178071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative characteristics of heart disease in systemic scleroderma and systemic lupus erythematosus].
    Guseva NG
    Vopr Revm; 1967; 7(2):54-9. PubMed ID: 5608166
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diffuse connective tissue diseases and malignant tumors].
    Nasonova VA; Guseva NG; Ivanova MM; Nesgovorova LI
    Klin Med (Mosk); 1985 Feb; 63(2):33-42. PubMed ID: 3990210
    [No Abstract]   [Full Text] [Related]  

  • 18. Microcirculation disorders in systemic connective tissue diseases.
    Guseva NG; Much ES; Balabanova RM
    Bibl Anat; 1975; 13():353-4. PubMed ID: 1231778
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the gastrointestinal system of children with inflammatory systemic connective tissue diseases].
    Rutkowska-Sak L; Legatowicz-Koprowska M; Ryzko J; Socha J
    Pediatr Pol; 1995 Mar; 70(3):235-41. PubMed ID: 8657492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the larynx in systemic lupus erythematosus and systemic scleroderma].
    Minchina RA; Fastovskiĭ IaA; Antonova NA
    Zh Ushn Nos Gorl Bolezn; 1970; 30(4):67-73. PubMed ID: 5503999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.